The US coronary stents market is projected to grow from $4.7 Bn in 2022 to $5.9 Bn by 2030, registering a CAGR of 2.75% during the forecast period of 2022-30. The US coronary stents market is driven by several factors, including the high prevalence of coronary artery disease (CAD) in the US, advances in stent technology, and increasing demand for minimally invasive procedures. The market is highly competitive, with several major players such as Abbott Laboratories, Boston Scientific Corporation, and Medtronic dominating the market. These companies invest heavily in research and development to develop innovative stent technologies that provide better outcomes for patients.
The US contraceptive devices market is projected to grow from $5.4 Bn in 2022 to $8.6 Bn by 2030, registering a CAGR of 6% during the forecast period of 2022-30. The US contraceptive devices market is a growing and dynamic market that includes a range of products designed to prevent pregnancy. Bayer is a German multinational pharmaceutical company that manufactures a range of contraceptive products, including oral contraceptives and IUDs.
The US cardiac surgery instruments market is projected to grow from $0.9 Bn in 2022 to $1.2 Bn by 2030, registering a CAGR of 4.6% during the forecast period of 2022-30. This growth is primarily due to an increasing number of cardiac surgeries, especially in the elderly population, and the adoption of advanced surgical instruments. The market is highly competitive, with several established players including B. Braun Melsungen AG, CONMED Corporation, Johnson & Johnson Services, Inc., Medline Industries, Inc., and Stryker Corporation. These companies offer a wide range of cardiac surgery instruments and compete on the basis of product quality, innovation, and pricing.
The US cardiac monitoring device market is projected to grow from $12.1 Bn in 2022 to $15 Bn by 2030, registering a CAGR of 2.7% during the forecast period of 2022-30. The US cardiac monitoring device market is expected to continue growing as the demand for accurate and reliable Cardiac Monitoring devices increases. Medtronic is a leading medical device company that offers a range of cardiac monitoring devices, including implantable cardiac monitors, pacemakers, and defibrillators.
The US ENT devices market is projected to grow from $9.7 Bn in 2022 to $13.1 Bn by 2030, registering a CAGR of 3.75% during the forecast period of 2022-30. The rising prevalence of ENT disorders, such as hearing loss, sinusitis, and tonsillitis, is a major driver of the ENT device market. According to the National Institute on Deafness and Other Communication Disorders, approximately 15% of American adults (37.5 million) aged 18 and over report some trouble hearing. The market is highly competitive, with a large number of players operating in the space, ranging from small, specialized companies to large multinational corporations. Some of the key players in the market include Cochlear Limited, William Demant Holding A/S, Medtronic plc, Stryker Corporation, and Olympus Corporation.
The US diabetes devices market is projected to grow from $4.7 Bn in 2022 to $5.9 Bn by 2030, registering a CAGR of 2.75% during the forecast period of 2022-30. Some of the key trends in the US diabetes devices market include the development of more advanced glucose monitoring and insulin delivery technologies, the use of digital health platforms and apps to help patients manage their diabetes, and the shift towards value-based care models that prioritize patient outcomes and cost-effectiveness. The US diabetes devices market is highly competitive, with several major players dominating the market. Some of the key players in the market include Abbott Laboratories, Medtronic, Dexcom, Roche, and Insulet Corporation.
The US biomaterials in the healthcare market are projected to grow from $65.6 Bn in 2022 to $153.4 Bn by 2030, registering a CAGR of 11.2% during the forecast period of 2022-30. Chronic diseases such as cardiovascular disease, cancer, and diabetes are on the rise in the US. The market is highly competitive, with several key players, including BASF SE, DSM NV, Invibio Ltd., Carpenter Technology Corporation, Evonik Industries AG, and Royal DSM. These companies invest heavily in research and development to develop new biomaterials and improve the performance of existing ones.
The US 3D printing medical devices market is projected to grow from $1.2 Bn in 2022 to $3.6 Bn by 2030, registering a CAGR of 14.3% during the forecast period of 2022-30. 3D printing enables medical devices to be customized to the individual patient's needs, which can improve patient outcomes and satisfaction. The US 3D printing medical devices market is highly competitive, with several established players and new entrants vying for market share. Some of the major players in the US 3D printing medical devices market include Stratasys, Stryker Corporation, 3D Systems, and Materialise NV
The Vietnam Neurology Device Market is expected to witness growth from $63 Mn in 2022 to $xx Bn in 2030 with a CAGR of xx% for the forecasted year 2022-2030. The Neurology devices market in Vietnam is being driven by the increase in neurological disorders like epilepsy, Parkinson's disease, and Alzheimer's disease. The market is segmented by product type and by the end user. Some key players in this market include Medtronic, Johnson and Johnson, GE Healthcare, Stryker, Abbott laboratories and Philips Healthcare.
The Tanzania neurology device market is expected to witness growth from $xx Bn in 2022 to $xx Bn in 2030 with a CAGR of xx% for the forecasted year 2022-2030. Tanzania has a high prevalence of neurological conditions like seizures, stroke, neurodegenerative diseases, neuromuscular disorders, and neuro-infections. The demand for neurology devices in the nation will rise as these diseases become more common. The market is segmented by product type and by the end user. Some key players in the market include Johnson and Johnson, GE Healthcare, Stryker, Medtronic, Penumbra and Abbott Laboratories.
The Nigeria Neurology Device Market is expected to witness growth from $11 Mn in 2022 to $xx Mn in 2030 with a CAGR of xx% for the forecasted year 2022-2030. The Prevalence of Neurological illnesses has increased in Nigeria, which results in increasing demand for neurology devices. The market is segmented by product type and by the end user. Some key players in this market include Me Cure Healthcare, Johnson and Johnson, GE Healthcare, Stryker, Medtronic, Abbott Laboratories and Philips Healthcare.
The Morocco Neurology Device Market is expected to witness growth from $16 Mn in 2022 to $xx Mn in 2030 with a CAGR of xx% for the forecasted year 2022-2030. In Morocco, the incidence of neurological conditions like seizures, stroke, and Parkinson's disease is rising. Ageing populations, shifting lifestyle preferences, and growing public knowledge of neurological disorders all contribute to this. It is anticipated that this rising prevalence will raise the demand for Neurology Devices in Morocco. The market is segmented by product type and by the end user. Some key players in this market include Promamec, Johnson and Johnson, GE Healthcare, Stryker, Medtronic, Abbott Laboratories and Philips Healthcare.
The Mexico Neurology Device Market is expected to witness growth from $189 Mn in 2022 to $xx Mn in 2030 with a CAGR of xx% for the forecasted year 2022-2030. Mexico's population is quickly ageing, with an increase in the proportion of people over 60. Age increases a person's vulnerability to brain diseases like Alzheimer's, Parkinson's, and stroke. The demand for neurology devices used in the diagnosis and treatment of these disorders, such as neurostimulation devices and imaging systems, is anticipated to increase as a result of this demographic tendency. The market is segmented by product type and by the end user. Some key players in this market include Johnson and Johnson, GE Healthcare, Stryker, Medtronic, Abbott Laboratories and Philips Healthcare.
The Libya Neurology Device Market is expected to witness growth from $xx Bn in 2022 to $xx Bn in 2030 with a CAGR of xx% for the forecasted year 2022-2030. In Libya, the prevalence of neurological illnesses has grown, which has led to a rise in demand for neurology devices. The market is segmented by product type and by the end user. Some key players in this market include Johnson and Johnson, GE Healthcare, Stryker, Medtronic, Abbott Laboratories and Philips Healthcare.
The Lebanon Neurology Device Market is expected to witness growth from $xx Bn in 2022 to $xx Bn in 2030 with a CAGR of xx% for the forecasted year 2022-2030. The prevalence of neurodegenerative diseases like Alzheimer's and Parkinson's disease is rising in Lebanon as the population matures. The demand for Neurology devices, such as diagnostic instruments or brain stimulation devices, may increase as a result of the expanding patient population. The market is segmented by product type and by the end user. Some key players in this market include Johnson and Johnson, GE Healthcare, Stryker, Medtronic, Abbott Laboratories and Philips Healthcare.
The Egypt Neurology Device Market is expected to witness growth from $35 Mn in 2022 to $72 Mn in 2030 with a CAGR of 9.30% for the forecasted year 2022-2030. There is a rising need for neurology devices in Egypt due to the frequency of neurological disorders such as stroke, epilepsy, Parkinson's disease, and multiple sclerosis. The market is segmented by product type and by the end user. Major Key players in Malaysia's neurology devices market include Wassenburg Medical, EMG-EP Technologies, Johnson and Johnson, GE Healthcare, Stryker, Medtronic and Abbott laboratories.
The Algeria Neurology Device Market is expected to witness growth from $25 Mn in 2022 to $xx Mn in 2030 with a CAGR of xx% for the forecasted year 2022-2030. The Prevalence of Neurological illnesses has increased in Algeria, which is increasing the demand for neurology devices. The population is ageing, habits are changing, and there are environmental issues to blame for this. The market is segmented by product type and by the end user. Some key players in this market include: Techno Brain Group, Biodeal Laboratories, Johnson and Johnson, GE Healthcare, Stryker, Medtronic and Abbott laboratories
The UK 3D Printing Medical Devices market size was valued at $77 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 14.3% from 2022 to 2030 and will reach $ 225 Mn in 2030. The market is segmented by component, application, , technology, and end user. The UK 3D Printing Medical Devices market will grow as the development of new 3D printing materials and techniques has led to the production of more complex and customizable medical devices. The key market players are Renishaw plc, Sutrue, Axial3D, Adapttech, FDM Digital Solutions, 3D LifePrints, Opro Mouthguards, Toffeln, PrintLab, Added Scientific and others.
The UAE 3D printing medical devices market size was valued at $15 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 17.3% from 2022 to 2030 and will reach $53 Mn in 2030. The market is segmented by component, application, technology, and end user. The UAE 3D Printing devices market will grow as 3D printing technology makes it possible to create medical devices that are specifically tailored to the anatomy and needs of each patient. The key market players are Sinterex, Immensa Technology Labs, Structo, Mediclinic Middle East, 3D Systems, Stratasys, Materialise: and others.
The Spain 3D Printing Medical Devices market size was valued at $57 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 15.3% from 2022 to 2030 and will reach $179 Mn in 2030. The market is segmented by component, application, technology, and end user. The Spain 3D Printing Medical Devices market will grow medical devices manufactured to order using 3D printing provide new opportunities for improving patient care and creating ground-breaking treatments. The key market players are BCN3D Technologies (ESP), Regemat3D (ESP), EMO3D (ESP), Intamsys (ESP), Nanofabrica (ESP), Grupo Sicnova (ESP), Microlay (ESP), Zerintia Technologies (ESP), Mimetis Biomaterials (ESP), 3D Surgical Technologies (ESP), Dental Global Service (ESP), and others.
The Italy 3D Printing Medical Devices market size was valued at $71 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 15.8% from 2022 to 2030 and will reach $230 Mn in 2030. The market is segmented by component, application, technology, and end user. The Italy 3D Printing Medical Devices market will grow The 3D printing technology has made a significant impact in the medical industry by enabling the production of personalized and complex medical devices. The key market players are Some of the key players in the market include 3D-Side, EGO3D, Mecuris Italia, MT Ortho, REJOINT, Storm Line, WASP MED, and others.
The India 3D Printing Medical Devices market size was valued at $54 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 17.8% from 2022 to 2030 and will reach $222 Mn in 2030. The market is segmented by component, application, technology, and end user. The India 3D Printing Medical Devices market will grow as the 3D printing technology allows for the customization of medical devices, which is becoming increasingly important in the healthcare industry. The key market players are 3D Life Prints, Osteo3d, Ayushman3D, Anatomiz3D Medtech, SLM Solutions, EOS, and others.
The Germany 3D Printing Medical Devices market size was valued at $109 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 14.5% from 2022 to 2030 and will reach $321 Mn in 2030. The market is segmented by component, application, technology, and end user. The Germany 3D printing medical devices market will grow as the 3D printing technology has made a significant impact in the medical industry by enabling the production of personalized and complex medical devices. The key market players are Some of the key players in the market include SLM Solutions Group AG, EOS GmbH, Concept Laser GmbH, Materialise NV, Stratasys Ltd, 3D Systems Corporation, and others.
The France 3D Printing Medical Devices market size was valued at $82 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 15.3% from 2022 to 2030 and reach $255 Mn in 2030. The market is segmented by component, application, , technology, and end user. The 3D-printed medical devices market in France will grow as the development of new 3D printing materials and techniques leads to the production of more complex and customizable medical devices. The key market players are AnatomikModeling, EOS, Impression 3D Médicale, InSimo, OsseoMatrix, Poietis, and SpineVisionare, among others.
The Australia 3D Printing Medical Devices market size was valued at $36 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 17.8% from 2022 to 2030 and will reach $132 Mn in 2030. The market is segmented by component, application, technology, and end user. The Australia 3D Printing Medical Devices market will grow as the 3D printing technology has made a significant impact in the medical industry by enabling the production of personalized and complex medical devices. The key market players are Some of the key players in the market include Anatomics, Osteopore, MELD Manufacturing Corporation, 3D Medical Limited, Stratasys, Materialise, Strykerand others.